News & Publications

NEWS & PUBLICATIONS

Learn more about Prous Institute and our progress in drug discovery, technology, industry partnerships, collaborations and scientific articles.


Prous Institute for Biomedical Research is pleased to announce the publication of its new WIPO patent application: Pyrano[3,2-c][2]benzopyran-6(2H)-one derivatives and uses thereof.  Claimed  compounds have shown inhibitory activity against SGLT2 (type 2 sodium-glucose linked transporter) and have displayed positive effects in glycemia control in animal models. SGLT2 inhibitors promote t...


A new paper published by US FDA scientists (In silico modeling to predict drug-induced phospholipidosis; Sydney S. Choi, Jae S. Kim, Luis G. Valerio Jr., Nakissa Sadrieh;  Toxicol Appl Pharmacol. 269 (2013) 195–204) explores the use of Prous Institute’s SYMMETRY® in the construction and validation of QSAR models for the identification of drug-induced phospholipidosis (DIPL). T...


Berlin, Germany: Prous Institute for Biomedical Research has announced the presentation of study results using its proprietary computational platform, Symmetry®, to identify molecular and cellular targets involved in neuroplasticity and tumor cell proliferation at the 22nd International Symposium on Medicinal Chemistry organized by the European Federation of Medicinal Chemistry (EFMC). Prous...


Berlin, Germany: Prous Institute for Biomedical Research presented the 2012 Prous Institute – Overton & Meyer Award, recognizing outstanding contributions to the development of new technologies in the field of medicinal chemistry, to Dr Harren Jhoti, at the 22nd International Symposium on Medicinal Chemistry organized by European Federation of Medicinal Chemistry (EFMC). This award ack...


Vienna, Austria: Prous Institute for Biomedical Research and the FDA Center for Drug Evaluation and Research (CDER) will present the results of their work to develop reliable mutagenicity models with a new release of Prous Institute’s Symmetry® computational platform and FDA/NCTR Mold2 descriptor package.  Prous Institute and the FDA/CDER are jointly presenting the research findings...

Page 6 of 8First   Previous   1  2  3  4  5  [6]  7  8  Next   Last